Astrazeneca rises on progress with diabetes drug

22nd Nov 2013 15:28

Shares in biopharmaceutical business AstraZeneca received a boost on Friday afternoon after the company, alongside sector peer Bristol-Myers Squibb, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) had recommended approval of Xigduo, a treatment for adult type two diabetic patients. NR

Top Risers

Share	Price	Change
Itm Power (ITM)	133.20	41.93%
PipeHawk (PIP)	3.50	40%
Trafalgar Prop (TRAF)	0.0325	32.65%
Ensilica (ENSI)	61.50	17.14%
Cora Gold (CORA)	11.75	14.63%

Top Fallers

Share	Price	Change
Digital 9 (DGI9)	4.80	-30.23%
Quantum Helium (QHE)	0.032	-20.99%
Workspace (WKP)	329.60	-11.78%
Arc Minerals (ARCM)	0.50	-9.09%
Mothercare (MTC)	1.07	-8.94%

Top By Volume

Share	Price	Volume
Quantum Helium (QHE)	0.032	3,182,265,363
Premier African Minerals (PREM)	0.0195	2,666,867,974
Ethernity Net (ENET)	0.0027	576,662,086
Caledonian Hold (CHP)	0.0042	257,198,228
Trafalgar Prop (TRAF)	0.0325	201,464,377

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.